| (Values in U.S. Thousands) | Dec, 2024 | Sep, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
| Sales | 345,940 | 316,700 | 332,100 | 312,270 | 327,050 |
| Sales Growth | +9.23% | -4.64% | +6.35% | -4.52% | +7.38% |
| Net Income | 33,750 | 48,980 | 29,980 | 19,710 | 33,070 |
| Net Income Growth | -31.09% | +63.38% | +52.11% | -40.40% | +108.78% |
C O N M E D Corp (CNMD)
23.94 x 2 73.33 x 1
Pre-market by (Cboe BZX)
59.85 -0.50 (-0.83%) 03/27/25 [NYSE]
23.94 x 2 73.33 x 1
Pre-market 59.85 unch (unch) 19:00 ET
for Thu, Mar 27th, 2025
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Fiscal Year End Date: 12/31